Trial 0S-15-13


Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism

Type: Prevention
Phase: Phase I/II
Status: Not Open (Closed)
Treatments: Other
Randomized: Yes
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Caroline Piatek, M.D.
Other Trial Staff:  Christine Duran, Coordinator, Ibrahim Syed, Coordinator, Sondra Ortiz, R.N., Teresa Olea, R.N., Anastasia Martynova, D.M., Donna Fernando, R.N., Ibrahim Meena, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.